Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model
Authors:
- 13 March 2017
- journal article
- research article
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 15 (9) , 815-826
Abstract
CD4+ T cells are essential for sustaining CD8+ T cell responses during a chronic infection. The adoptive transfer of virus-specific CD4+ T cells has been shown to efficiently rescue exhausted CD8+ T cells. However, the question of whether endogenous virus-specific CD4+ T cell responses can be enhanced by certain vaccination strategies and subsequently reinvigorate exhausted CD8+ T cells remains unexplored. In this study, we developed a CD4+ T cell epitope-based heterologous prime-boost immunization strategy and examined the efficacy of this strategy using a mouse model of chronic lymphocytic choriomeningitis virus (LCMV) infection. We primed chronically LCMV-infected mice with a Listeria monocytogenes vector that expressed the LCMV glycoprotein-specific I-Ab-restricted CD4+ T cell epitope GP61-80 (LM-GP61) and subsequently boosted the primed mice with an influenza virus A (PR8 strain) vector that expressed the same CD4+ T cell epitope (IAV-GP61). This heterologous prime-boost vaccination strategy elicited strong anti-viral CD4+ T cell responses, which further improved both the quantity and quality of the virus-specific CD8+ T cells and led to better control of the viral loads. The combination of this strategy and the blockade of the programmed cell death-1 (PD-1) inhibitory pathway further enhanced the anti-viral CD8+ T cell responses and viral clearance. Thus, a heterologous prime-boost immunization that selectively induces virus-specific CD4+ T cell responses in conjunction with blockade of the inhibitory pathway may represent a promising therapeutic approach to treating patients with chronic viral infections.Keywords
This publication has 50 references indexed in Scilit:
- Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)Proceedings of the National Academy of Sciences, 2013
- Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infectionProceedings of the National Academy of Sciences, 2011
- Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infectionProceedings of the National Academy of Sciences, 2010
- The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responsesCurrent Opinion in Immunology, 2009
- Enhancing SIV-specific immunity in vivo by PD-1 blockadeNature, 2008
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infectionNature Immunology, 2008
- Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockadeProceedings of the National Academy of Sciences, 2008
- Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivoJournal of Virological Methods, 2008
- Heterogeneity and Cell-Fate Decisions in Effector and Memory CD8+ T Cell Differentiation during Viral InfectionImmunity, 2007
- Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class IIVirology, 2007